CoChat

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

Open access
Daina, Antoine, Michielin, Olivier, Zoete, Vincent · 2017 · Scientific Reports

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Abstract

To be effective as a drug, a potent molecule must reach its target in the body in sufficient concentration, and stay there in a bioactive form long enough for the expected biologic events to occur. Drug development involves assessment of absorption, distribution, metabolism and excretion (ADME) increasingly earlier in the discovery process, at a stage when considered compounds are numerous but access to the physical samples is limited. In that context, computer models constitute valid alternatives to experiments. Here, we present the new SwissADME web tool that gives free access to a pool of fast yet robust predictive models for physicochemical properties, pharmacokinetics, drug-likeness and medicinal chemistry friendliness, among which in-house proficient methods such as the BOILED-Egg, iLOGP and Bioavailability Radar. Easy efficient input and interpretation are ensured thanks to a user-friendly interface through the login-free website http://www.swissadme.ch . Specialists, but also nonexpert in cheminformatics or computational chemistry can predict rapidly key parameters for a collection of molecules to support their drug discovery endeavours.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep42717

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 SwissADME submission page. The actual input is a list of SMILES, which contains one molecule per line with an optional name separated by a space. Molecules can be directly pasted or typed in SMILES format, or inserted through the molecular sketcher. The latter enables importing from databases, opening a local file or drawing a 2D chemical structure to be transferred to the list by clicking on the double-arrow button. When the list of molecules is ready to be submitted, the user can start the calculations by clicking on the “Run” button.
Figure 1 SwissADME submission page. The actual input is a list of SMILES, which contains one molecule per line with an optional name separated by a space. Molecules can be directly pasted or typed in SMILES format, or inserted through the molecular sketcher. The latter enables importing from databases, opening a local file or drawing a 2D chemical structure to be transferred to the list by clicking on the double-arrow button. When the list of molecules is ready to be submitted, the user can start the calculations by clicking on the “Run” button.CC BY · PubMed Central
Figure 2 Computed parameter values are grouped in the different sections of the one-panel-par-molecule output (Physicochemical Properties, Lipophilicity, Pharmacokinetics, Drug-likeness and Medicinal Chemistry). The panel is headed by the molecule name and an up-arrow button to scroll to the top of the page. The molecule is first described by its chemical structure and canonical SMILES together with the Bioavailability Radar (see Fig. 3). Contextual help can be displayed by leaving the mouse over the radar or different question mark icons next to some parameters.
Figure 2 Computed parameter values are grouped in the different sections of the one-panel-par-molecule output (Physicochemical Properties, Lipophilicity, Pharmacokinetics, Drug-likeness and Medicinal Chemistry). The panel is headed by the molecule name and an up-arrow button to scroll to the top of the page. The molecule is first described by its chemical structure and canonical SMILES together with the Bioavailability Radar (see Fig. 3). Contextual help can be displayed by leaving the mouse over the radar or different question mark icons next to some parameters.CC BY · PubMed Central
Figure 3 The Bioavailability Radar enables a first glance at the drug-likeness of a molecule. The pink area represents the optimal range for each properties (lipophilicity: XLOGP3 between −0.7 and +5.0, size: MW between 150 and 500 g/mol, polarity: TPSA between 20 and 130 Å2, solubility: log S not higher than 6, saturation: fraction of carbons in the sp3 hybridization not less than 0.25, and flexibility: no more than 9 rotatable bonds. In this example, the compound is predicted not orally bioavailable, because too flexible and too polar.
Figure 3 The Bioavailability Radar enables a first glance at the drug-likeness of a molecule. The pink area represents the optimal range for each properties (lipophilicity: XLOGP3 between −0.7 and +5.0, size: MW between 150 and 500 g/mol, polarity: TPSA between 20 and 130 Å2, solubility: log S not higher than 6, saturation: fraction of carbons in the sp3 hybridization not less than 0.25, and flexibility: no more than 9 rotatable bonds. In this example, the compound is predicted not orally bioavailable, because too flexible and too polar.CC BY · PubMed Central
Figure 4 The BOILED-Egg 17 allows for intuitive evaluation of passive gastrointestinal absorption (HIA) and brain penetration (BBB) in function of the position of the molecules in the WLOGP-versus-TPSA referential. The white region is for high probability of passive absorption by the gastrointestinal tract, and the yellow region (yolk) is for high probability of brain penetration. Yolk and white areas are not mutually exclusive. In addition the points are coloured in blue if predicted as actively effluxed by P-gp (PGP+) and in red if predicted as non-substrate of P-gp (PGP−). For an interactive analysis, the user can leave the mouse over a dot to show the structure of the molecule and click on the dot to scroll to the corresponding output panel. In this example, Lapatinib is predicted as not absorbed and not brain penetrant (outside the Egg), Omeprazol is predicted well-absorbed but not accessing the brain (in the white) and PGP+ (blue dot), Sunitinib is predicted as passively crossing the BBB (in the yolk), but pumped-out from the brain (blue dot), and Palonosetron is predicted as brain-penetrant (in the yolk) and not subject to active efflux (red dot). One molecule is predicted not absorbed and not BBB permeant because outside of the range of the plot (streptomycin with a TPSA of 331.43 Å 2 and a WLOGP of −7.74).
Figure 4 The BOILED-Egg 17 allows for intuitive evaluation of passive gastrointestinal absorption (HIA) and brain penetration (BBB) in function of the position of the molecules in the WLOGP-versus-TPSA referential. The white region is for high probability of passive absorption by the gastrointestinal tract, and the yellow region (yolk) is for high probability of brain penetration. Yolk and white areas are not mutually exclusive. In addition the points are coloured in blue if predicted as actively effluxed by P-gp (PGP+) and in red if predicted as non-substrate of P-gp (PGP−). For an interactive analysis, the user can leave the mouse over a dot to show the structure of the molecule and click on the dot to scroll to the corresponding output panel. In this example, Lapatinib is predicted as not absorbed and not brain penetrant (outside the Egg), Omeprazol is predicted well-absorbed but not accessing the brain (in the white) and PGP+ (blue dot), Sunitinib is predicted as passively crossing the BBB (in the yolk), but pumped-out from the brain (blue dot), and Palonosetron is predicted as brain-penetrant (in the yolk) and not subject to active efflux (red dot). One molecule is predicted not absorbed and not BBB permeant because outside of the range of the plot (streptomycin with a TPSA of 331.43 Å 2 and a WLOGP of −7.74).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Research works printed but not linked: 2

  1. Wolf, C. R., Smith, G. & Smith, R. L. Pharmacogenetics. British Medical Journal (2000).
  2. Zoete, V., Daina, A., Bovigny, C. & Michielin, O. SwissSimilarity. A web tool for low to ultra high-throughput ligand-based virtual screening. J. Chem. Inf. Model. 58, 1399–1404 (2016). · DOI · Paper page

Cited by

Items 801–900 of 1,022

Metadata

Authors
Daina, A., Michielin, O., & Zoete, V.
Affiliations
SIB Swiss Institute of Bioinformatics (CH)
Corresponding author
  • Michielin, Olivier
  • Zoete, Vincent
Venue
Scientific Reports
Published
2017-03-03
Volume
7
Issue
1
Pages
42717-42717
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2593436234
Cited by
18,367
References
75
Citations by year
2026: 3348 · 2025: 3624 · 2024: 3255 · 2023: 2767 · 2022: 2268 · 2021: 1559 · 2020: 990 · 2019: 342 · 2018: 160 · 2017: 32
FWCI
315.41
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion, other-oa)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
  • IRIS (submittedVersion, other-oa)
Funders
  • SystemsX.ch
  • Swiss Institute of Bioinformatics
  • Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Physical Sciences › Physics and Astronomy › Atomic and Molecular Physics, and Optics › Advanced Chemical Physics Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
Keywords
SwissADME, ADME prediction, pharmacokinetics, drug-likeness, physicochemical properties, small molecules, boiled eggs, web-based tool, drug discovery
MeSH terms
Software, Small Molecule Libraries, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.